PKM2 pS222 levels in the tumors from patients (73 cases) with low‐grade diffuse astrocytoma (WHO grade II; median survival time >5 years) were compared with those in the tumors from patients (48 cases) with high‐grade GBM. This evidence concerns the gene PKM and glioblastoma.